Corbus Pharmaceuticals Holdings, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Adjustments to Additional Paid in Capital, Warrant Issued of $807.15 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-08.
Discontinued › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2022-03-08
- Corbus Pharmaceuticals Holdings, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2020-12-31 was $334.74K.
- Corbus Pharmaceuticals Holdings, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2020-09-30 was $472.41K.
- Corbus Pharmaceuticals Holdings, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2018-12-31 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2018-09-30 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2020 was $807.15K.
- Corbus Pharmaceuticals Holdings, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2018 was $6.22M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 0 month | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $334.74K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $807.15K derived: sum of 2 quarters · filed 2022-03-08 | $807.15K 10-K · filed 2022-03-08 | ||
| 2020-09-30 | $472.41K 10-Q · filed 2021-11-12 | $472.41K 10-Q · filed 2021-11-12 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $0.00 derived: sum of 2 quarters · filed 2020-03-16 | $0.00 derived: sum of 3 quarters · filed 2020-03-16 | $6.22M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $6.22M 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $6.22M 10-Q · filed 2019-08-08 | |||
| 2018-03-31 | $6.22M 10-Q · filed 2019-05-09 | ||||
| 2014-06-30 | $48.38K 10-K · filed 2016-03-28 | $48.38K 10-Q · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |